New advances in the use of antimicrobial agents in surgery: Intra- abdominal infections

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 453-463

  Cinat, Marianne E ^a   Wilson, S E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Antibiotics; Antimicrobials; Beta lactams; Carbapenems; Cephalosporins; Fluoroqui nolones; Intra abdominal infection; Surgical infections; Therapy; Treatment

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTETAN; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINAFLOXACIN; CLINDAMYCIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TAZOSYN; TIMENTIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ANAEROBIC BACTERIUM; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MIXTURE; ENTEROBACTERIACEAE; HUMAN; HYPOGLYCEMIA; PENICILLIN ALLERGY; PHOTOSENSITIVITY DISORDER; PNEUMONIA; SURGICAL INFECTION;

EID: 0033402414     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.453     Document Type: Conference Paper

References (47)

1. 1 Edmiston CE Jr, Goheen MP, Kornhall S, Jones FE, Condon RE. Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 1990; 14: 176-183.
2. 2 Sugimoto K, Hirata M, Takishima T, Ohwada T, Shimazu S, Kakita A. Mechanically assisted intraoperative peritoneal lavage for generalized peritonitis as a result of perforation of the upper part of the gastrointestinal tract. J Am Coll Surg 1994; 179: 443-448.
3. 3 Butler J, Huang J, Wilson SE. Repeated laparotomy for postoperative intra-abdominal sepsis: an analysis of outcome predictors. Arch Surg 1987; 122: 702-706.
4. 4 Harris JA, Jury RP, Catto J, Glover JL. Closed drainage versus open packing of infected pancreatic necrosis. Am Surg 1995; 61 (7): 612-618.
5. 5 Stabile BE, Puccio E, VanSonnenberg E, Neff C. Preoperative percutaneous drainage of diverticular abcesses. Am J Surg 1990; 159: 99-105.
6. 6 Hemming A, Davis N, Robins E. Surgical versus percutaneous drainage of intra-abdominal abscesses. Am J Surg 1991; 161: 593-595.
7. 7 Malangoni M, Shumate C, Thomas H, Richardson J. Factors influencing the treatment of intra-abdominal abcesses. Am J Surg 1990; 159: 167-171.
8. 8 Mosdell DM, Morris DM, Volutra A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214 (5): 543-549.
9. 9 Bohnen J, Solomkin J, Dellinger E, Bjornson H, Page C. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A surgical infection society policy statement. Arch Surg 1992; 127: 83-89.
10. 10 Fass R, Prior R. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob Agents Chemother 1989; 33, 8: 1268-1274.
11. 11 Wilson SE, Nord C. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections: European and North American experience. Am J Surg 1995; 169 (Suppl 5A): 21S-26S.
12. 12 Marshall SA, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers: a reevaluation after five years. Diagn Microbiol Infect Dis 1995; 21 (3): 153-168.
13. 13 Murray PR, Cantrell HF, Lankford RB. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria: in vitro susceptibility surveillance group. Diagn Microbiol Infect Dis 1994; 19 (2): 111-120.
14. 14 Thornsberry C. Trends in antimicrobial resistance among today's bacterial pathogens. Pharmacotherapy 1995; 15 (1 Pt 2): 3S-8S.
15. 15 Yellin AE, Heseltine PN, Berne TV, et al. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet 1985; 161 (4): 303-307.
16. 16 Walker A, Nichols R, Wilson R, et al. Efficacy of a β-lactamase inhibitor combination for serious intra-abdominal infections. Ann Surg 1993; 217 (2): 115-121.
17. 17 Weigelt J, Easley S, Thal E, Palmer L, Newman V. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy. J Trauma 1993; 34 (4): 579-585.
18. 18 Sirinek KR, Levine BA. A randomized trial of ticarcillin clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet 1991; 172 (Suppl): 30-35.
19. 19 Fink MP. Antibiotic therapy of intra-abdominal sepsis in the elderly: experience with ticarcillin and clavulanic acid. Surg Gynecol Obstet 1991; 172 (Suppl): 36-41.
20. 20 Aronoff SC, Jacobs MR, Johenning S, Yamabe S. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam, combined with amoxicillin or ampicillin. Antimicrob Agents Chemother 1984; 26 (4): 580-582.
21. 21 Gutmann L, Kitzis MD, Yamabe S, Acar JF. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases. Antimicrob Agents Chemother 1986; 29 (5): 955-957.
22. 22 Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Antimicrob Agents Chemother 1986; 29 (6): 980-985.
23. 23 Brismar B, Malmborg AS, Tunevall G, et al. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob Agents Chemother 1992; 36 (12): 2766-2773.
24. 24 Niinikoski J, Havia T, Alhava E, et al. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. Surg Gynecol Obstet 1993; 176: 255-261.
25. 25 Polk H Jr, Fink M, Laverdiere M, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. Am Surg 1993; 59 (9): 598-605.
26. 26 Ravichandran D, Karran SE, Pallet A, Davey PG, Karran SJ. Monotherapy versus combination therapy in serious intra-abdominal infections: a prospective randomized study. Br J Surg 1994; 81 (Suppl): 75.
27. 27 Thornsberry C, Yee YC. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med 1996; 24; 100 (6A): 26S-38S.
28. 28 Barie P, Vogel S, Dellinger E, et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Arch Surg 1997; 132: 1294-1302.
29. 29 Okamoto MP, Chin A, Gill MA, et al. Analysis of cefepime tissue penetration into human appendix. Pharmacotherapy 1991; 11 (5): 353-358.
30. 30 Chang D, Wilson SE. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections. Am J Surg 1997; 174: 284-290.
31. 31 Gonzenbach HR, Simmen HP, Angwerd R. Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin: a controlled and randomized comparison in intra-abdominal infections. Ann Surg 1987; 205 (3): 271-275.
32. 32 Poenaru D, De Santis M, Christou NV. Imipenem versus tobramycin-antianaerobe antibiotic therapy in intra-abdominal infections. Can J Surg 1990; 33 (5): 415-422.
33. 33 Solomkin J, Dellinger E, Christou N, Busuttil R. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 1990; 212 (5): 581-591.
34. 34 Eckhauser F, Knol J, Raper S, Mulhollan M, Helzerman P. Efficacy of two comparative regimens in the treatment of serious intra-abdominal infections: results of a multicenter study. Clin Therapeut 1992; 14 (1): 97-109.
35. 35 De Groot HG, Hustinx PA, Lampe AS, Oosterwijk WM. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1993; 32 (3): 491-500.
36. 36 Solomkin J, Reinhart H, Dellinger E, et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. Ann Surg 1996; 223 (3): 303-315.
37. 37 Angeras M, Darle N, Hamnstrom K, et al. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. Scand J Infect Dis 1996; 28: 513-518.
38. 38 Patel JB, Giles RE. Meropenem evidence of lack of proconvulsive tendency in mice. J Antimicrob Chemother 1989; Suppl A: 307-309.
39. 39 Kanellakopoulou K, Giamarellou H, Papadothomakos P, et al. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 1993; 12 (6): 449-53.
40. 40 Brismar B, Malmborg A, Tunevall G, et al. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1995; 35: 139-148.
41. 41 Huizinga W, Warren B, Baker L, et al. Antibiotic monotherapy with meropenem in the surgical managementx of intra-abdominal infections. J Antimicrob Chemother 1995; 36 (Suppl A): 179-189.
42. 42 Geroulanos SJ. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. J Antimicrob Chemother 1995; 36 (Suppl A): 191-205.
43. 43 Condon R, Walker A, Sirinek K, et al. Meropenem versus tobramycin plus clindamycin for treatment of intra-abdominal infections: results of a prospective, randomized, double-blind clinical trial. Clin Infect Dis 1995; 21: 544-550.
44. 44 Berne T, Yellin A, Appleman M, Heseltine N, Gill M. Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis. J Am Coll Surg 1996; 182: 403-407.
45. 45 Hooper D, Wolfson J. Fluoroquinolone antimicrobial agents. N Engl J Med 1991; 324 (6): 384-394.
46. 46 Hopkins J, Wilson SE, Shimabukuro J, Chavez C. Susceptibility of anaerobic flora recovered from complicated intra-abdominal infections to clinafloxacin and imipenem. Presented at Anaerobic Society Meeting, April 1998, Argentina.
47. th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1998, San Diego, CA.